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ABSTRACT
The Combined Effects of Leptin and Coenzyme Q10 in Ameliorating Obesity- Induced
Infertility in Female Rats
by
Adekunle O. Adedeji
Infertility is one of the major problems of obesity. Studies have shown that
administration of leptin reversed obesity-induced infertility in rats and mice. Coenzyme
Q10 (CoQ10) is an antioxidant and also supplies the energy needed for ovulation and
embryo development. We hypothesized that leptin when combined with CoQ10 could
greatly improve obesity-induced infertility. The results showed a significant decrease in
food intake, body weight, and the regular estrous cycle was restored after treatment
with leptin+CoQ10. There was a significant increase (p<0.05) in follicle stimulating
hormones after treatment. It was observed that CoQ10 significantly (p<0.05) downregulates the expression of β-catenin in the ovary while E-cadherin failed to be
expressed. In conclusion, administration of leptin with CoQ10 can improve fertility in
obese infertile female rats. This study could provide a novel therapeutic strategy for the
treatment of infertility and formulation of new drugs for the treatment of obesity-induced
infertility in females.
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CHAPTER 1
INTRODUCTION
Leptin
Leptin is a 16kDa protein product produced by obese (ob) gene. It was first
identified and characterized in 1994 by Zhang et al 82. Leptin is secreted primarily by
adipose tissue (fat cells) mainly white adipose tissue 82 and produced in a small amount
by the skeletal muscle, mammary gland, placenta and stomach 13. It plays a significant
role in the physiologic functions of the body by regulating food intake, body weight and
energy expenditure 17. Leptin regulates the neuroendocrine, metabolic, reproductive as
well as immunological processes 13. Leptin exerts its main effects on the nuclei of the
basomedial hypothalamic area of the brain where leptin receptors are located 19.
The Role of Leptin in Food Intake and Energy Expenditure
The major function of the leptin is to maintain homeostatic control of fats by
regulating the food intake, body weight and energy expenditure 17. Leptin is secreted
primarily by the adipose tissue (fat cells), released into the blood stream and then
transported to the hypothalamus of the brain2. One of the major functions of the
hypothalamus is to regulate food intake and energy expenditure by recognition of
peripheral signals such as leptin 43. Once leptin is released into the blood stream by the
adipose tissue, it is transported to the brain where it binds with the neurons of the leptin
receptors (LEPR) located within the nuclei of the basomedial hypothalamus; arcuate
(ARC), dorsomedial hypothalamic and ventromedial hypothalamic nuclei of the brain.
The neurons relay information about the energy status of the body to the brain 19. The
neurons exhibit two forms; orexigenic (increases appetite) and anorexigenic (decreases
11

appetite) neuropeptides. orexigenic neuropeptides expression modulated by leptin
include Neuropeptide Y (NPY), agouti-related protein (AGRP), melanin-concentrating
hormone (MCH), orexin, galanin and galanin-like peptide (GALP) 19. Anorexigenic
peptides expression modulated by leptin include pro-opiomelanocortin (POMC),
cocaine- and amphetamine-regulated transcript, neurotensin, corticotropin-releasing
hormone (CRH) and brain-derived neurotrophic factor 7. Studies have shown that
central administration of orexigenic neuropeptides such as NPY increase food intake
and decrease the energy expenditure53. Central administration of leptin causes leptin to
bind with the LEPRs located within the nuclei of the basomedial hypothalamus
(particularly ARC), thereby inhibiting secretion of orexigenic neuropeptides (which
stimulate appetite) but stimulate the release of anorexigenic neuropeptides to decrease
appetite. This results in decrease in food intake and increase in energy expenditure with
respect to the total body fats and body mass index 53. NPY is associated with the
regulation of gonadotropin-releasing hormone (GnRH) by binding directly with GnRH via
the brain and / or pituitary and thus regulates gonadotropin secretion (Fig. 2). The
GnRH stimulates anterior pituitary to release follicle stimulating hormone (FSH) for
folliculization and luteinizing hormone (LH) stimulates the gonads in preparedness for
ovulation (Fig. 2). In 1996, Schwartz et al. demonstrated that the level of circulating
leptin in peripheral blood is dependent on total body fat and body mass; The higher the
total body fat and the body mass index the higher the circulating leptin 64. When fat
mass falls, the circulating leptin level falls, stimulating appetite and suppressing energy
expenditure until the fat mass is restored. However, when fat mass increases,
circulating leptin level also increases, suppressing appetite until the weight is lost. This
12

mechanism by leptin helps the body to maintain and regulate homeostatic control and
energy balance of the body 47. Other factors that causes an increase in circulating leptin
include food intake 41,40, glucose uptake 73 and gender- higher in females than males 56.
However, exercises37 and an increase in age56 can also decrease the level of circulating
leptin.
Leptin Receptors
Leptin receptors (LEPRs) are classified as class 1 cytokine receptors because it
has a common downstream signal pathway and homologous structure with interleukin 6
36

. LEPRs are located mainly in the hypothalamus, site for control of appetite,

reproduction, growth and metabolism 43. LEPR are also expressed in small amounts in
other parts of the brain such as the cerebellum, anterior pituitary and other parts of
tissues such as placenta and stomach 43. Leptin receptor family arises from alternative
splicing, consists of six isoforms called obese receptors (ob-R) isoforms and are
grouped into two forms; short and long forms. The short forms include ob-Ra, ob-Rc,
ob-Rd, ob-Rf, and soluble form, ob-Re which circulates in the plasma. The only long
isoform, ob-Rb is mainly expressed in the hypothalamus 17. The ob-Rb contains a long
intracellular domain which has two protein motifs that signal via Janus-activated
kinases (JAK)-signal transducers and activators of transcription (JAK-STAT) pathway 70.
The short intracellular isoforms signal via phosphatidyl inositol-3 (PI-3) kinase or
mitogen-activated protein kinase (MAPK) pathway. The short forms do not activate JAKSTART pathway because they contain only one of the two JAK – binding domains 70.
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Leptin binds with LEPR majorly in the hypothalamus and activates different signals that
relay information regarding the physiological status of the body to the brain 2.
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Fig. I. Biological response of leptin in low (starvation/fasting) and high levels (obesity).
During starvation/fasting/hunger, there is a decrease in adiposity which leads to a
decrease in concentration of leptin in the blood. Leptin binds to leptin receptors in the
hypothalamus of the brain and conversely activates several pathways; increase
NPY/AgRP, neuropeptide Y/Agouti-related peptide; decrease POMC,
proopiomelanocortin; CART, cocaine- and amphetamine-regulated transcript. This
pathway relays the information about the energy status of the body to the brain and
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ultimately leads to increase food intake and a decrease in energy expenditure as well as
metabolism. However, in conditions such as obesity, the reverse is the case. Several
hormones are involved in leptin response to energy status. These include; gonadotropin
releasing hormone (GnRH), corticotrophin release hormone (CRH), melaninconcentrating hormone (MCH), thyroid-stimulating hormone (TSH), thyroid-releasing
hormone (TRH), adrenocorticotropic hormone (ACTH), growth hormone (GH); IGF-I,
insulin-like growth factor I as well as reproductive hormones such as luteinizing
hormone (LH), follicle-stimulating hormone (FSH) and estrogen 32, 64.
Role of Leptin in Obesity, Infertility and Reproduction
One of the neglected underlying causes of infertility is obesity. Infertility is
associated with obesity and overweight, especially when it occurs at the early stage of
life or during puberty 57. Obesity reduces the chances of ovulation and pregnancy in
women that ovulate regularly 26. Previous studies suggested that the impairments in
fertility caused by obesity has its reproductive targets on hypothalamus, ovary, ovarian
follicle, oocyte, embryo as well as uterine endothelium 79,8, 77, 61, 71. The role of leptin in
infertility was first demonstrated in 1997 by Chehab 18. It was observed that defective
ob/ob female mice whose failure to make leptin were attributed to a gene mutation that
prevented the mice from ovulating and thus resulted to infertility due to hormonal
abnormalities (gonadotropin secretion impairment) 18. Fertility was restored after
administration of exogenous leptin18. The success of reproduction is dependent on food
intake and energy reserves of the body 57. Pasquali and Gambineri study showed that
excessive fat accumulation in adipose tissue (fat cells) and the associated release of
high concentrations of free fatty acids into various organs can impair fertility 57.
15

Evidently, there is a linkage between nutritional status, obesity, and reproduction 55.
Previous researchers have also demonstrated that leptin is involved in reproduction;
neuroendocrine regulation of prolactin, luteinizing hormone, estrogen, follicle stimulating
hormone, progesterone and GnRH 1,24. Leptin has its effects on the hypothalamus–
pituitary–gonadal (HPG) axis, viz-a-vis, gonadal, adrenal, thyroid, pancreatic islet, and
growth hormone 17. Study by Yu et al. in rats showed that leptin can directly stimulate
the release of gonadotropin-releasing hormone (GnRH) from the hypothalamus and
luteinizing hormone (LH) from the pituitary 80. This finding was also corroborated in a
study by Zieba, Amstalden, & Williams in cattle 83. The hypothalamic control of
gonadotropin secretion is regulated by GnRH 80 which has effects on reproduction17.
Hypothalamus (Leptin + LEPR)

NPY

BBB

Leptin

POMC

Adipose
tissue

GnRH
Anterior pituitary

FSH

LH

Folliculization

Gonads

Energy
Balance

(Ovulation)

Fig. 2. Response of leptin in the reproductive system.
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The adipose tissue stimulates the synthesis of leptin which is then transported to the
brain (hypothalamus) via the blood-brain barrier (BBB) where different neuropeptide
signals are being activated. Leptin binds with leptin receptors in the preoptic area of the
hypothalamus and causes an increase in gonadotropin-releasing hormone (GnRH)
secretion. The GnRH stimulates anterior pituitary to release follicle stimulating hormone
(FSH) for folliculization and luteinizing hormone (LH) for stimulation of the gonads in
preparedness for ovulation (Fig. 2).
Epithelium Cadherin and Beta Catenin
Epithelium Cadherin (E-cadherin)
Cadherin belongs to the superfamily of transmembrane glycoproteins that
contain repeated units of approximately 100 residues in their extracellular domain. The
primary function of cadherin is to mediate calcium dependent cell-cell interaction and
also play key roles in normal tissue development and proliferation of many organs 68.
Disruption of cadherin function has been linked to different kind of developmental and
pathological conditions such as cancer 76. The classical cadherin subfamily includes E,
P, R, B and N and other different subtypes. The subtypes are given the name
depending on the site they are found. For example, E- cadherin, the most studied
member of the family is found in the epithelial tissue 45. N-cadherin is found in the
neuron; P-Cadherin is found in the placental; R-cadherin in the retina; VE- Cadherin in
vascular endothelial 4. E-cadherin also known as cadherin 1 is a protein that is encoded
by CDH1, tumor suppressor gene in human 76. It consists of five repeated cadherin
residue, EC1 to EC5 in the extracellular domain, one transmembrane domain, and an
17

intracellular domain (cytoplasmic tail) that interact with p120-catenin and beta catenin.
The intracellular domain contains a highly-phosphorylated region and facilitates the
binding to β-catenin, and thus promotes cell to cell interaction with E-cadherin function.
E-cadherin down-regulation decreases the strength of cellular adhesion within a tissue,
resulting in an increase in cellular motility 76.
Beta Catenin
Beta (β-) catenin also known as catenin beta-1 is a CTNNB1 protein encoded by
CTNB1 gene in human 46. It was discovered that mammalian β- catenin is homologous
both in structure and function with drosophila protein called armadillo. Armadillo (ARM)
is a repeated unit of amino acids (approximately 40) folded into single, elongated, rigid
protein domain. The armadillo is involved in mediating the morphogenic effects
of Wingless/Wnt 38. β-catenin is a subtype of catenin protein family and homologous to
γ-catenin (plakoglobin). It is expressed in tissue such as cardiac muscle and ovary 59.
The β-catenin is a key downstream effector protein in the Wnt signaling pathway that
has been linked to different kind of developmental and pathological conditions such as
cancer 16. β-catenin is involved in two major biological processes: early embryonic
development 75 and tumorigenesis 60. β-catenin is involved in cell to cell adhesion as
well as gene transcription 74.
E-cadherin/β-Catenin Complex
E-cadherin cytoplasmic domain is linked to the actin cytoskeleton through the β
catenin, Y catenin and p120 catenin to form cell to cell adhesion junction. The β and Ycatenin is linked to α- catenin to form E-cadherin/β-catenin complex which in turn linked
18

to the actin cytoskeleton. This complex formation enables the E-cadherin to maintain
the structural integrity and polarity of the epithelial cells and tissues. β and Y-catenin
play structural roles in the junctional complex while p120 regulates the adhesive activity
and trafficking 74.
E-cadherin/β-Catenin Complex Expression in Rat Ovary
Expression of E-cadherin/β-catenin complex is involved in the development of
tissues and proliferation of organs

68

. E-cadherin/β-catenin complex expression is

increased in the theca and interstitial cells of the rat ovaries during follicular
development. However, granulosa cell has more expression of β-catenin

67

. The

cytoplasmic tail of E-cadherin (plasma membrane) is linked to β-catenin (nucleus) to
form a complex that helps in the regulation of cytoskeletal structures and intracellular
signaling. Studies have shown that modulation of E-cadherin/β-catenin complex
expression forms an integral component of remodeling processes which include
folliculogenesis and corpus luteum formation in the ovary 67. During these processes, Ecadherin/β-catenin complex is under the influence of hormones such as estrogen30.
Coenzyme Q10
Coenzyme Q10 (CoQ10) is a fat-soluble vitamin-like compound 3 produced
naturally in most cells of the body with higher concentration found in tissues with high
energy stores (mitochondria) such as the brain, heart, liver, kidney 27. The oocyst
(ovary) has the highest number of mitochondria and mitochondrial DNA more than any
cells with high energy requirements such as muscle cells and neurons 10. CoQ10 can
also be found in small amounts in diets such as meats (especially organ meats),
19

sesame oil, soybeans, nuts, dark leafy green vegetables like spinach, kale and broccoli,
seafood, and avocado 14. CoQ10 is made up of benzoquinone and a hydrophobic tail
that comprises of isoprenoids units which can be reduced to ubisemiquinone and finally
reduced to ubiquinol which is the biological active 69. There are two forms of CoQ10;
ubiquinone and ubiquinol. CoQ10 starts off as ubiquinone and converted to the more
potent active antioxidant, ubiquinol in the cell. Most CoQ10 supplements are available in
the form of ubiquinone. ubiquinol does not need to be converted by the body. The main
function of CoQ10 is the transfer of electron in the mitochondrial electron transport chain,
used for adenosine triphosphate (ATP) synthesis through ATP synthetase. The ATP
synthesis is responsible for creating cellular energy. CoQ10 is also a powerful lipidsoluble antioxidant, its tissue concentration is about five to ten folds higher than the
main fat- soluble antioxidants such as vitamin E 9. It inhibits lipid peroxidation by
providing protection and scavenging free radical or oxidant damage caused by reactive
oxygen species (ROS) or reactive nitrogen species (RNS) in the mitochondria 42

Fig. 3. The role of CoQ10 in mitochondria Electron transport chain. Molnar et al. (2013) 85
”
20

CoQ10 has shown to be a promising compound in the management and treatment of a
wide range of diseases partly or directly caused by mitochondrial disorder such as
ischemic heart disease, muscular degeneration, Parkinson, Alzheimer, epilepsy,
Diabetes, congestive heart failure, hypertension, cancer, as well as infertility 66,10,14.
Increase in age, as well as administration of drugs such as Statins decrease the
concentration of CoQ10 in tissues 49. CoQ10 increases ATP synthesis in the mitochondria
thus enhancing mitochondrial function and decreases the oxidative stress that causes
DNA damage in both animals and human 10. Studies have shown that the presence of
ubiquinol in the cell membrane help to reduce cell and DNA damage caused by free
radicals, which has a negative impact on health 10. Bentov, Esfandiari, Burstein, &
Casper (2010) study showed that mitochondrial DNA damage can be reversed by the
supplementation with antioxidants particularly CoQ10 10. In reproduction, CoQ10
increases the availability of energy for egg quality, sperm motility, maturation of oocyte,
embryo development as well as implantation in infertile females10. The survival and
quality of oocyte in the ovary rely extensively on the production of ATP, therefore, an
increase in the concentration of CoQ10 in the plasma could produce a desirable and
positive outcome in fertility. The study conducted by Burstein et al., (2009) in mice
concluded that supplementation of CoQ10 improves mitochondrial function as well as an
ovarian response in old mice. It has also been shown that combination of CoQ10 with
other supplements such as Zinc, lipoic acids, omega-3 fatty acid, vitamins C and E
improves mitochondrial disorders than when used alone 1,68. Also, findings from
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Rodriguez et al. study in 2007 showed that combination of CoQ10 with other
supplements such as lipoic acid and creatine was more effective in the treatment of
mitochondrial disorders than the lone pair in health related diseases 62. Abdali, Samson,
and Grover (2015) study also described that antioxidants supplementations are
beneficial in the management of type 2 diabetes and obesity, especially when
supplemented with a combination of antioxidants such as Vit C, E, Lipoic acid, Zinc than
CoQ10 alone. The study also recommended testing this hypothesis in high energy health
related disease such as infertility 1. Tarnopolsky (2008) also corroborated other
researches that supplementation of CoQ10 with another compound could greatly
improve and produce positive impacts in fertility than lone administration 69. It is
important to conduct this research among females because females are the first target
during diagnosis of infertility among couples. With significant evidence showing a
positive effect of leptin in reversing obesity-induced infertility and CoQ10 showing a
promising outcome in the treatment of some disease conditions such as male infertility,
it is important to test if the combination of leptin with CoQ10 could actually yield a more
positive outcome in obesity-induced infertility in female rats. This study is novel
research as there is no available data on effects of the combination of leptin and CoQ10
in obesity-induced female infertility. This study could provide a therapeutic strategy for
the treatment of infertility as well as formulation of new drugs for the treatment of
obesity-induced infertility in females.

22

Hypothesis
The combination of leptin and CoQ10 greatly improve obesity-induced infertility in
female rats.
Objectives
To measure the spleen weight, body weight and food intake.
To measure the total antioxidants level in the blood.
Evaluation of expression of β- catenin and E-cadherin proteins in the ovary.
Evaluation of expression of leptin receptors in the hypothalamus.
Determination of plasma level of luteinizing, estrogen and follicle stimulating hormones.
Evaluation of total body composition of each group of the rats.
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CHAPTER 2
MATERIALS AND METHODS
Animals Model
Twenty-one female Sprague-Dawley rats of weight range 150-250g were
acquired from Harland and used in this study (Protocol #100501). The animal use
protocol was approved by the University Committee on Animal Care (UCAC) of East
Tennessee State University. Animals were housed individually and kept in a wellcontrolled, specific pathogen-free room, located in the Brown Hall DLAR facility at
ETSU. Food and water were made available ad libitum. Four of the rats were fed
regular chow diet (RCD), and the remaining seventeen were fed with high-fat diet (HFD)
to induce infertility.
Determination of Oestrus Cycle
A normal regular oestrus cycle of rats is between 4-5 days and consists of
proestrus, estrus, metestrus, and diestrus stages (Fig. 4). Vaginal cytology is used to
determine different stages of the estrous cycle. A vaginal cytology was conducted using
a wet mount process to visualize the vaginal cells. A small amount (10µl) of saline
solution was introduced into the vaginal orifice of each rat and then aspirated and
placed on a clean dry grease free slide. The cells were then checked using a compound
microscope at 10X and 40X for analysis.

24

Fig 4. Microscopy view of oestrus cycle stages
Vaginal smears pictures that were taken at 10X using digital camera microscope.
Each of the pictures represents stages of the oestrus cycle.
(A). Proestrus: Predominance of nucleated epithelial cells.
(B). Estrus: Predominance of anucleated cornified cells.
(C). Metestrus: Nucleated epithelial cells, anucleated cornified cells, and leukocytes.
(D). Diestrus: Predominance of leukocytes.
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Irregular Oestrus Cycle
The irregularity of the oestrus cycle of the rats fed with HFD was first noticed
toward the end of the 12th week of the study (Fig. 5), which signified the onset of
infertility. Infertility occurs when any of the stages; proestrus, estrus, metestrus, or
diestrus of the 4-day oestrus cycle is skipped particularly estrus phase or maintained for
more than two days. The ability of each rat to go through a 4-day cycle without skipping
any stage signifies a regular oestrus cycle. The rats’ body weight and food intake were
measured twice weekly while the estrus cycle checked daily until the oestrus cycle
became disrupted.

Fig 5. Representation of an irregular oestrus cycle.
The irregular oestrus cycle moved from (A) Proestrus: predominance of nucleated
epithelial (skipping estrus stage) to (B) Metestrus: nucleated epithelial cells, anucleated
cornified cells, and few leukocytes, and then (C) Diestrus: predominance of leukocytes.

26

Animals were divided into five groups and treated as follows:
Group I:

Fed regular chow diet (RCD), received d-alpha tocopheryl polyethylene
glycol 1000 succinate (TPGS) (10mg/ml/kg/b.w/day) intraperitoneally (i.p).

Group II:

Fed high fat diet (HFD), received TPGS (10mg/ml/kg/b.w/day) for two
weeks intraperitoneally (i.p)

Group III:

Fed HFD, received leptin (100ug/ml/kg/b.w/twice/day) for two days i.p.

Group IV:

Fed HFD, received CoQ10 (100mg/ml/kg/b.w/day) for two weeks i.p

Group V:

Fed HFD, received leptin (100ug/ml/kg/b.w/twice/day) for two days and
CoQ10 (100mg/ml/kg/b.w/day) i.p .

Table 1: Groups and treatments administered
Group
I
II
III
IV
V

Name
RCD
HFD
HFDleptin
HFDCoQ10
HFDleptin+CoQ10

Diet
CHOW
HFD
HFD
HFD
HFD

Leptin
+
+

CoenzymeQ10
+
+

TPGS
+
+
+
+
+

High-fat diet (HFD), regular chow diet (RCD), Tocopheryl polyethylene glycol 1000
succinate (TPGS). TPGS (10mg/ml/kg/b.w/day), leptin (100ug/ml/kg/b.w/twice/day)
CoQ10 (100mg/ml/kg/b.w/day).
Group I was fed a regular chow diet (RCD) while groups II to V were fed a highfat diet (HFD) for 14 weeks to induce infertility. Estrous cycle was checked daily. Food
intake and body weight measured twice weekly before and after treatments. All the
animals were sacrificed fourteen days after the last day of treatments (18 weeks).
Blood, tissues and carcasses were collected for further analysis.
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Blood and Tissue Collection
Blood samples were collected from each rat into a 5 ml EDTA tube and placed
on ice. It was later centrifuged at room temperature for 10 minutes at 2000Xg using
Sorvall Legend XTR centrifuge (Thermo scientific, USA). Once centrifuged, the
supernatant (plasma) was pipetted into 3ml glass amber vials and stored at -30 °C for
further analysis of leptin, antioxidant status, ferric reducing ability of plasma (FRAP) and
reproductive hormones concentrations. The red blood cell (RBC) pellet at the bottom of
the EDTA tube was diluted with equal parts of normal saline (0.9% NaCl), vortexed
briefly to disrupt the RBC pellet, and centrifuged for 5 minutes at 2000Xg. The clear
supernatant was removed and discarded. This process was repeated two more times
with the clear supernatant removed and discarded each time. Red blood cell pellet of
100 µl was transferred to clear 150mm screw-top test tube with Teflon lined caps and
2ml of n-hexane, 95% (Fisher Scientific, cat. # 130939) was. This process was done in
duplicate and stored at 30OC prior to fatty acid methylation of the RBC.
FRAP Assay
The plasma was evaluated for antioxidant capacity using a spectrophotometric
technique, ferric reducing ability of plasma (FRAP) assay, as described and modified by
Benzie & Strain (1996). It works on the principle that the intensity of the color produced
is directly proportional to the concentration of antioxidant present in the sample read at
an absorbance of 593nm. FRAP assay is used to determine total antioxidant capacity in
serum/plasma samples. The FRAP reagent was prepared fresh before each series of
measurements to ensure validity. The reagent contained the following materials: 200 ml
of acetate buffer (300mM, pH 3.6), 20 ml TPTZ solution (0.062 g 2,4,6-tripyridyl-s28

triazine, or TPTZ, in 20ml 40mM HCl), 20 ml FeCl3 solution (0.2748 g FeCl3-6H2O in
50 ml DDW), and 24ml DDW. Frozen plasma samples were thawed at room
temperature. The absorbance was determined against a blank containing 1000µl of
FRAP reagent and 80µl of DDW. The sample preparation contained 20µl of the
sample, 60 ul DDW, and 1ml of FRAP reagent. The standard curve was calibrated using
a series of standards from diluting 1mM ferrous sulfate solution. The concentration for
the series of dilutions included: 0.1, 0.2, 0.4 at increasing increments until the
concentration reached 1.0mM. FRAP values were determined by UV-visible
spectrophotometer (Thermo Scientific, BioMate 3S cat. # 840-208400) read at 593nm.
An average FRAP value of the triplicate samples was determined for each individual
measured. Each study group average FRAP values were determined and overall mean
for each case group was calculated.
Hormonal Assays using ELISA kits
Leptin (Life Technologies, cat. # KRC2281), FSH (Biotang, cat. # R6403), LH
(Shibayagi, cat. # AKRLH-010S) and estrogen (Calbiotech, cat. #ES180S-100) were
measured using rats’ ELISA kit according to manufacturers’ protocols with microplate
reader.
Tissues Harvesting and Analysis
Tissues removed from the rats such as ovary, hypothalamus were immediately
snap frozen in liquid nitrogen and stored at -80 oC for homogenization and Western
Blotting. The remaining body carcasses were stored at -80 oC for later proximal analysis
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to determine the percentage of crude protein, fats, minerals, total calories and fatty
acids profiles of isolated fat.
Western Blotting for Expressions of E-cadherin, β- catenin and Leptin Receptor
E-cadherin, β-catenin (from the ovary) and leptin receptors (from the
hypothalamus) expressions were examined using Western blots. Each sample was
homogenized using RIPA lysis buffer (Triton X-100 10%, Sodium Deoxycholate1%,
SDS 0.10%, NaCl 0.15M, NaH2P04 0.01M, NaF 50mM, EDTA 2mM) containing
protease inhibitor cocktail (Thermo scientific, cat. #78442) and the cell lysates extracted
upon refrigerator centrifugation. The protein concentration of the cell lysates was
determined by bicinchoninic acid (BCA) assay protein (Thermo scientific kit, 23236).
Protein samples were run with ladder (Fisher scientific, cat # BP 3603-500) and
separated by electrophoresis on 8-12% SDS-polyacrylamide gel and electro-transferred
onto hybond-ECL nitrocellulose membranes. Blotted membranes were blocked for 1hr
with 2% non-fat milk at room temperature. The membranes were washed in 10% TBST
contains 1xTris buffered saline (Mediatech, Inc. cat. #46-012-CM) with
10%Tween® 20 (Acros, cat #9005-64-5) three times at 5mins each. They were
incubated with primary antibodies diluted 1:1000 (5ug of primary antibody to 5ml TBST)
for E-cadherin and β-catenin while leptin receptor at 1:2000 overnight at 4oC. The
primary antibodies used were mouse antibody (Cell Signaling Technology Cat#14472s)
for E- cadherin, rabbit antibodies (Cell Signaling Technology Cat# 8480S
RRID:AB_11127855) for β-catenin and leptin receptor (rabbit IG) (Thermo Fisher
Scientific Cat# PA1-053 RRID:AB_2296991). β-actin (Sigma-Aldrich Cat# F3022
RRID:AB_476970). After primary antibody incubation, the blots were washed three
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times in TBST for 5minutes each before been probed with secondary antibody
conjugated with horseradish peroxidase at a dilution of 1:10000 (5ug to 50ml of TBST
plus with 2% non-fat milk) at 40c overnight. The secondary antibodies used are goat
anti-mouse (Cell Signaling Technology Cat# 7076S, RRID:AB_10695470) for Ecadherin and goat anti-rabbit (Thermo Fisher Scientific Cat# 31460 RRID:AB_228341)
for β-catenin and leptin receptor. After the incubation with secondary antibody, it was
washed three times in TBST at 5minutes each. The HRP-conjugated antibody–
chemoluminescence reagent, Lumigen TMA-6 solution A and B (Catalog no TMA-100)
from Lumigen® ECL Ultra was used for visual development by mixing 1 parts of solution
A to 1 part of solution B. The substrate was incubated on the membranes for 5minutes
under dark. Excess solution was removed and blot images were obtained using
chemoluminescence digital imaging, Fluorchem M. Protein simple (Santa Clara, CA,
U.S.A).
Total Body Assay
The total body and feeds compositions were conducted using proximal analysis
techniques; Soxhlet method was used to evaluate percentage crude fat, Kjeldahl
method for percentage of crude protein, bomb calorimetry for total calories and “ashing”
for total inorganic content.
Sample Preparation for Proximal Analysis
Whole animal carcass and feeds were weighed and freeze dried using a freeze
dryer (Labconco Freezone 2.5 Cat.# 7670520) (Fig. 6) to remove the water content.
Whole animals’ carcasses and feeds were reweighed after drying. The samples were
then grounded, sieved and then stored at -30 0C for later analysis.
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Fig. 6. Samples on freeze dryer (Labconco Freezone 2.5)

Kjehldhal Analysis
This method is used to evaluate the percentage of crude protein present in the
sample.1000-1200mg of the sample was measured into Kjeldahl flask (place flask in
250ml beaker to hold upright).1.9 g of K2SO4, 80 mg of mercuric oxide, 2 ml of
concentrated H2SO4 and 2 boiling chips were added into the flask with gentle mixing for
1-2 minutes. The Kjeldahl flask was placed on the burner with the neck of the flask
inserted into the glass manifold. The heater was switched to 3 with the air on under the
hood. It was refluxed for 8 to 12 hours (sample will look clear with black specks). It was
allowed to cool, 10ml of deionized distilled water was added and the mixture was
filtered. It was distilled by placing beaker with 5 ml of boric acid with several drops of
Kjeldahl indicator at the bottom of the apparatus. The sample was added slowly to the
top of the distilled apparatus. 10ml of NaOH/Na2O3S2 was added slowly (solution
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turned black). The total volume of boric acid was allowed to measure 20-30ml, blue in
color. The solution was titrated back with 0.1N dilute HCl until changed to steady pink.
The samples were run in duplicates. Percentage of crude protein was calculated using
the nitrogen content of the sample as follows;
Nitrogen (g)/kg = (ml-HCl – ml blank) x Normality x 14.01/ weight (g) x aliquot volume.
Soxhlet Analysis
This method is used to determine the percentage of fatty acids present in a
sample. 2.5g of the sample was mixed thoroughly with 2.5g of anhydrous NaSO4 in
mortar and pestle. 2g of the mixture was placed into cellulose thimble, top with glass
wool, and labeled the thimble with a pencil. 175ml of petroleum ether (PET) was
measured into the round bottom flasks with 2 boiling chips and the thimble was put into
Soxhlet sample extraction chamber. The assembled apparatus includes; round bottom
flask (seated at the base), Soxhlet extraction chamber (middle), and condenser on top.
Each condenser was attached firmly to each other by tubing. The water was turned on
and a steady stream of water going through it with the light on. The mantle heater was
turned to 3 and allowed to reflux for 8-12 hours. After reflux, it was allowed to cool off
(10-20 minutes) by turning off the heat, drained the fluid from thimble into Soxhlet
extraction chamber and finally into round bottom flasks. The drained thimbles were
placed in an oven at 60 0c for 24 hours, allow to cool in a desiccator for about 1-2hours
and then reweighed. The samples were run in duplicates. The percentage of crude fatty
acids was calculated as;
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Soxhlet = ((weight. before extraction (g) –Weight. after extraction (g))/ Weight before
extraction) x 100
Ashing Analysis
This method is used to evaluate the percentage of crude organic minerals
present in a sample. Crucible was first weighed. 5g of the sample was transferred into
the crucible and then placed in an oven (Heat) at 7000C for 5 – 24 hours. The crucible
plus sample was placed in a desiccator (1-2 hours) after “ashing” to cool and then
reweighed. The percentage organic minerals (Ash) is calculated as:
Percentage Ash = ((Weight before- Weight after ashing)/ weight before)) x100.
Bomb Calorimetry
This method is used to measure the total calories present in a sample. About 1 –
1.2 g of sample was measured into combustion capsule. The combustion capsule was
then placed into ringer holder. The ignition thread was twisted around the wire and
draped into combustion capsule, making sure it touched the sample. The valve was
closed and charged with oxygen. 2000ml of deionized distilled water was added into the
chamber (water) bucket. “bomb” was placed into water bucket and ignition wires were
attached. The sample weight was input into the bomb calorimeter computer and start
sequence (Fig. 7). The “bomb” explodes the sample and print off the results. The bomb
was removed from the bucket and slowly release the combustion capsule assembly.
The “bomb housing” and combustion capsule assembly was rinsed with deionized
distilled water into a 250ml beaker. 2-4drops of methyl red indicator was added into the
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beaker and then titrated against 0.1N of NaoH until a yellow uniform color change is
observed. The samples were run in duplicates.
Total calories of dry matter = Calories on receipt – ml of titration (nitrogen)

Fig. 7. Paar 6200 Automatic Isoperibol Oxygen Bomb calorimeter.
Statistical Analysis
The Mean value and standard error of the mean were calculated for leptin, body
weight, food intake, spleen weight, FRAP, organic minerals, FSH, LH, estrogen, total
calories, crude protein, fatty acids, and CoQ10. Data was analyzed using general
descriptive models program in SPSS version 23 (IBM Corp. Armonk, NY, USA) and
Graph Pad statistical software (Prism 6 for window version 6.07 Graph Pad,
CA) using multiple comparisons (uncorrected Fisher’s LSD). The level of significance
was determined at p<0.05 for all analysis.
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CHAPTER 3
RESULTS
Leptin Regulates Body Weight
The average body weight of all the groups were monitored weekly before and
after the treatments with digital weighing scale. There was a decrease in the body
weights of the groups treated with HFD leptin and HFD leptin+CoQ10 when compared
with the control (HFD) at the 16th week when the treatments started (Fig. 8). This
correspond to previous published work showing that leptin decreases the body weight of
animals 25,31,58. Therefore, leptin plays a significant role in the regulation of body weight.
However, CoQ10 did not have an effect on body weight when used alone (Fig. 8).

.
Fig. 8. Effects of leptin and CoQ10 on the body weight.
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Table 2: Analysis of average weekly body weight of rats in grams and reported as the
mean ± standard error of the mean.
GROUP

WEEK 1

WEEK 4

WEEK 8

RCD

180.03±3.55

186.04±2.97

195.98±3.74

HFD

177.91+1.61

210.38±3.07

252.71+3.69

HFD+LEP
HFDCoQ1

181.16±0.94

208.03±5.25

250.6±4.13

0

179.93±1.61

206.24±5.59

248.11±6.45

HFDLEP+
CoQ10

182.35±2.41

205.8±5.03

247.33±6.95

WEEK 12
212.70±5.
44
287.94±6.
33
284.33±4.
18
281.71±7.
00
280.41±8.
97

WEEK 16
229.73±4.
46
317.82±5.
16
306.01±5.
99
309.93±6.
00
311.99±11
.27

WEEK 18
240.52±4.
86
333.17±3.
17
280.40±5.
47
326.16±7.
78
298.26±7.
08

WEEK 20
250.34±4.61
346.18+4.14
285.26±4.97
330.53±7.51
307.88±10.8
0

Leptin Regulates Food Intake
In this study, the average weekly food intake was measured using a digital
weighing scale. It was observed that there was a decrease in the food intake among the
treatments groups of HFD leptin and HFDleptin+CoQ10 when compared with the control,
HFD at the 16th week when the treatment started. This correspond to previous
published work28 showing that leptin is involved in the decrease in the appetite of the
rats which ultimately decreases their food intake, while CoQ10 did not show effects on
food intake in all the groups when used alone (Fig. 9). It was also observed that the
RCD control group consumed more food that the HFD groups, but this did not transform
to increase in their body weight due to lower fats and calorie contents in their feed
unlike the HFD (Fig. 9).
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Table 3: Analysis of average weekly food intake of rats in grams and reported as the
mean ± standard error of the mean.
Group

WK 1

WK 4

WK 8

WK 12

WK 16

WK 18

WK 20

RCD

17.52±1.69

15.65±0.68

15.95±0.63

16.37±1.28

16.57±0.68

16.15±0.58

15.87±0.73

HFD

17.76±1.16

10.46±0.34

10.68±0.25

10.47±0.33

10.41±.40

9.85±0.36

10.43±0.52

HFD+LEPT

16.85±1.35

11.7±1.2

11.6±1.80

11.65±0.05

11.2±0.4

7.5±0.3

8.9±0.3

HFD+CoQ10

16.67±0.83

10.32±0.20

10.3±0.11

10.85±0.69

10.025±0.46

9.5±0.28

9.76±0.16

HFDLEP+
CoQ10

15.4±1.57

10.76±0.17

11.53±0.27

11.33±0.63

11.40±0.15

9.23±0.21

9.46±0.46

.

Fig. 9 Effects of leptin and CoQ10 on food intake.
There was a decrease in the food intake observed in the HFD leptin and HFD
leptin+CoQ10 groups at week 16 of the treatment. This suggests that leptin plays a
significant role in the regulation of food intake.
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CoQ10 Increases Concentration of Plasma Leptin
The plasma leptin concentration was measured using ELISA. There was
statistical significance increase (p<0.05) in the level of plasma leptin in the
HFDCoQ10+leptin treatment group (p=0.03) when compared with control HFD (Fig. 10).
This suggests that CoQ10 enhances the concentration of leptin in the blood. Therefore,
combination of leptin and CoQ10 increases the concentration of leptin in the blood.

Fig. 10. Leptin concentration in the blood by ELISA.
The result showed an increase in the level of plasma leptin in HFDleptin+ CoQ10
treated groups when compared with HFD control group.
Reproductive Hormones Concentration in the Blood
Combination of Leptin with CoQ10 Regulates Follicle Stimulating Hormone (FSH)
Plasma FSH concentration was measured using ELISA. There was a significant
increase (P=0.0004) in the level of plasma concentration in the HFD leptin+CoQ10 group
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when compared with the control HFD (Fig.11). This suggests that combination of leptin
and CoQ10 could enhance the concentration of FSH in the blood.

Fig. 11. Follicle stimulating hormone (FSH) concentration by ELISA.
The results showed an increase in the level of FSH in HFD leptin+ CoQ10 treated
group (P=0.0004) when compared with HFD control group.
Regulation of Luteinizing Hormone (LH) by Leptin with CoQ10
Plasma LH was measured using ELISA. Leptin plus CoQ10 treated group showed
an insignificant increase (p> 0.05) in the level of plasma LH when compared with the
control HFD (Fig. 12). This suggests that leptin+CoQ10 may not have effect in the
regulation of LH in the blood.
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Fig. 12. Plasma luteinizing hormone (LH) concentration by ELISA.
The results showed statistically insignificance (p>0.05) increase in the level of LH
in HFD+ Leptin-treated group followed by HFD leptin+ CoQ10 when compared with HFD
control group.
Regulation of Plasma Estrogen Hormone (EH) By Leptin with CoQ10
Plasma EH was measured using ELISA. There was a slight insignificant increase
(p>0.05) in the level of EH in HFD leptin+CoQ10, HFDCoQ10, and HFD leptin treated
group when compared with the control HFD. This suggests that Leptin plus CoQ10 may
not have an effect on the regulation of plasma EH (Fig. 13).
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Fig. 13. Plasma estrogen concentration by ELISA.
The result showed an insignificance increase (p>0.05) in plasma estrogen in the
leptin-treated group when compared with HFD. However, no statistical significance was
observed (p>0.05) among the treated groups when compared with the HFD control
group.
Total Body Composition of Rats using Proximal Analysis
This is a system for approximating the value or materials of the body (animals,
foods) based on the body components. For this study, the rats’ total body compositions
were analyzed into different fractions according to their feeding values. The fractions
analyzed include; crude protein, crude fats (ether extract), inorganic content (ash) and
total calories.
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Effect of Leptin with CoQ10 on Crude Fat
The rat’s total body crude fat was estimated using the Soxhlet method. There
was significance increase, p=0.01 in the percentage of crude fats in the
HFDleptin+CoQ10 treated group when compared with HFD control group (Fig. 14). The
result suggests that leptin+CoQ10 could increase the percentage of total body crude fat.

TOTAL BODY
CRUDE FATS (%)

*

Fig. 14. Total body crude fat measurement by Soxhlet method.
The result showed statistical significance increase (p<0.05) in HFD leptin+ CoQ10
(p=0.01) treated group when compared with HFD control group.
Effect of Leptin with CoQ10 on Crude Protein
The percentage crude protein was assayed using Kjeldahl method. The result
showed no significance difference in the treated HFD leptin+CoQ10 when compared with
the control HFD (Fig. 15) (p>0.005). Hence, leptin combined with CoQ10 does not
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regulate crude protein in the body because CoQ10 functions as an antioxidant and

TOTAL BODY CRUDE
PROTEIN (%)

electron transport chain enhancer.

Fig. 15. Total body crude protein by Kjeldahl method
The result showed no statistical significance, p>0.05 in all the treated groups
when compared with HFD control group.
Effect of Leptin and CoQ10 on Total Body Inorganic Content.
The percentage of total body minerals was estimated using “ashing” method. The
result showed no statistical significance, p>0.05 in the treated group HFDleptin+CoQ10
when compared with HFD control group (Fig. 16). This shows that combination of leptin
and CoQ10 does not have an effect on the inorganic content of the body. However, the
higher amount seen in the RCD when compared with HFD may be connected with HFD
tying up minerals (fat) in the small intestine and excreting them.
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Fig. 16. Estimation of body inorganic content using “ashing” method.
The result showed no statistical significance, p>0.05 in all the treated group when
compared with HFD control group.
Leptin Combined with CoQ10 Regulates Total Body Calories
The total body calories were estimated using the “bomb” calorimetry method. The
result showed a significance increase in the total calories of the HFDLeptin+CoQ10
(p=0.0006) treated group when compared with the HFD control group (Fig. 17). This
indicates that combined leptin and CoQ10 could increase in total body calories.
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*

Fig.17A. Total body calories estimation using the “bomb” calorimetry method.

Amount of calories
(cal/g)

Comparison of Total Calories in
Diets
5400
5200
5000
4800
4600
4400
4200
4000
3800
RCD

HFD
Diet

Fig.17b. Comparison of average total calories in diets (RCD and HFD) consumed by
the rats. The HFD has more calories than RCD.
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Table 4: Comparison of average total calories in diets (cal/g) between regular chow diet
(RCD) and high-fat diet (HFD), reported as the mean± standard error of the mean.
RCD
4363.75±2.83

HFD
5209.335±2.21

CoQ10 is involved in immunological reaction of the body
The weight of the spleen was measured using a digital weighing scale. The result
showed that there was a significant weight increase (p<0.05) in the spleen weight of
HFDCoQ10 (p=0.0016) and HFDleptin+CoQ10 (p= 0.002) treated groups when compared
with the HFD control group (Fig 18). This suggests that CoQ10 has an effect on
immunological response in the body and thus improved immune function in the rats.
The effect may be attributed to splenomegaly observed in HFDCoQ10 and
HFDleptin+CoQ10 treated groups directly or partially caused by CoQ10 action in the
body.

Fig. 18. Graph showing spleen weight measured by digital weighing balance
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The results showed statistical significance increase in the spleen weight in
HFDCoQ10 (p=0.0016) and HFDleptin+CoQ10 (p= 0.002) groups when compared with
HFD control group.
Table 5: Analysis of average spleen weight in grams and reported as the mean±
standard error of the mean.
RCD
HFD
HFD+LEP
HFD+COQ10 LEP+COQ10
0.69225±0.031 0.706375±0.026 0.7035±0.020 0.961±.032
0.9767±0.145
Measurement of Total Antioxidants
Ferric reducing ability of plasma (FRAP) assay was used to estimate the total
antioxidant present in the plasma. The ferric reducing ability of plasma in the
HFDleptin+CoQ10 treatment group showed a statistical significance increase (p<0.05)
when compared with the HFD control group (Fig. 19). This result suggests that
combination of leptin with CoQ10 could help to enhance the protective effect of CoQ10
against free radicals that causes DNA damage in tissues.
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Fig.19. Plasma antioxidant concentration measured by FRAP assay.
The result showed statistical significance increase (p=0.0016) in the level of
antioxidants in HFD leptin+ CoQ10 treatment group when compared with HFD control
group.
Expression of Beta Catenin and Epithelium Cadherin in the Rats’ Ovary
In the study, the expression of β- catenin and E-cadherin were analyzed by
Western blot using the rats’ ovary lysate.
CoQ10 Down-Regulate the Expression of Beta Catenin in the Ovary
The result showed that CoQ10 down-regulated the expression of β- catenin in the
ovary (Fig. 20). β-catenin expression was higher in rats fed with HFD. However, there
was a decrease in expression in the HFDleptin+CoQ10 treatment group, followed by
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HFDCoQ10 and then HFD leptin treatment group when compared with HFD group (Fig.
20). This shows that CoQ10 down-regulates the expression of β-catenin in the ovary.

Fig. 20. Expression of β- catenin in the ovary by Western blot

*
*

*

Fig. 21. β- catenin quantification in the ovary
Quantification of the β-catenin showed significance decrease (p<0.05) in the
expression of β- catenin in leptin HFD, CoQ10 HFD and leptin+CoQ10+HFD treated
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groups when compared with HFD control. This shows that CoQ10 downregulates the
expression of β- catenin in the ovary.
Expression of E- cadherin in the ovary
In this study, expression of E-cadherin in the ovary was examined using western
blot. The result showed no detection of E-cadherin expression in all the groups at 135kd
(which is the size at which E- cadherin was to be expressed according to the protocol
used). However, multiple repeated analysis of the lysate for E-cadherin showed
consistent detection of an unidentified protein band expressed with E-cadherin antibody
at 50kd in all the groups (Fig. 22).

Fig. 22: Western blot showing band of unknown protein at 50kDa that was expressed
with E-cadherin antibody.
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Fig. 23. Western blot showing expression of E- cadherin with positive control (MCF-7)
A positive control, MCF-7 was run along with the samples. The positive control showed
expression of E-cadherin at 135kDa while samples showed expression of an unknown
protein that binds with E-cadherin antibody at 50kDa.
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Unknown protein quantification

Fig. 24: The unknown protein quantification in the ovary that shows expression with Ecadherin antibody.
Quantification of the unknown band showed no significance (p>0.05) among the
groups. However, there was a decrease in the expression of the band in
HFDleptin+CoQ10 and slight insignificance increase (p>0.05) in the expression between
HFD Leptin and HFD+CoQ10 treated groups when compared with HFD control group
(Fig. 24). This suggests that CoQ10 might decrease the expression of the band when
combined with leptin.
Leptin Receptor (LEPR) Expression in the Hypothalamus
Hypothalamus lysate was analyzed for expression of leptin receptor (LEPTR). In
this study, expression of long isoform (125KDa) and a short isoform (100kDa) of LEPTR
was checked. The LEPTRs, long and short forms were not expressed at the sizes;
125kDa and 100kDa respectively. However, there were small unknown proteins that
showed expression with leptin receptor antibody detected at sizes smaller than 70kDa.
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(Fig. 25). The protocol for the assay indicated that two smaller unrelated proteins could
be detected at 31kDa and 35kDa. Quantification of protein detected at 50kD was done
and analyzed (because of higher expression). The result showed downward regulation
of the unknown LEPTR in HFDLeptin+CoQ10 and HFD leptin groups when compared
with the HFD (Fig. 25).

Fig. 25: Western blot showing expression of small proteins that binds with LEPTR
antibody in the hypothalamus.
There was statistical significance (p<0.05) in the upward regulation of the small
LEPTR in RCD when compared with HFD group (Fig. 26). This shows that leptin tends
to decrease the expression of this small protein detected at the 50kDa. There was a
slight insignificant increase (p>0.05) in the expression of HFDCoQ10 treatment group,
when compared with the HFD group (Fig. 26).
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Fig. 26. Leptin receptor quantification in the hypothalamus
Quantification of the LEPTR showed significance decrease (P<0.05) in the
expression of the small unknown protein in HFD leptin and HFD leptin+CoQ10 treated
groups when compared with HFD control. From the graph above, it can be suggested
that there may be less small isoform of LEPTRs (if identified as LEPTRs protein) that
bind with the LEPTR antibody in the HFD leptin and HFD leptin+CoQ10 groups unlike
the HFD group. The decrease in expression can cause delay in relay of information of
energy status of the body to the brain, and this may have negative effect on
hypothalamic-pituitary-gonadal axis of the body.
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CHAPTER 4
DISCUSSION AND CONCLUSION
Leptin is a hormone synthesized primarily by adipose tissues and secreted into
the blood stream to drive physiological functions of the body. Leptin helps to regulate
food intake, body weight, immunological responses as well as infertility 6,36. Leptin has
been shown to reverse infertility as well as improve reproduction 82. Coenzyme Q10
(CoQ10) is an important component of electron transport chain in the mitochondria of
human and animal body cell. CoQ10 helps in the synthesis of ATP and acts as a
powerful antioxidant and quenches free radicals in the mitochondrial and lipid
membranes 62. Research has shown that CoQ10 helps in reproduction as well as
improved fertility 62. It has been suggested that antioxidant such as CoQ10
supplementation could alternate infertility and improve reproduction 62,69. Therefore, this
study focused on the combination effects of CoQ10 and leptin on infertile female rats.
Various results from this study indicate that combination of leptin with CoQ10 can play a
significant role in biological functions that could results in an increase in reproductive
functions as well as fertility.
The first observation from the study was the role of leptin in the regulation of food
intake, body weights, and energy expenditure. The food intake and body weight of the
rats were monitored before and after treatment. This was measured to determine if
leptin, CoQ10 and leptin plus CoQ10 reduce food intake and body weight. Previous
researches have shown that leptin plays a key role in regulatory centers to reduce feed
intake, regulate the body weight and energy expenditure of animals 25,31,58. Results (Fig.
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VIII) showed that reduction in the body weight started at week 16 when the treatment
started among the treated groups, HFD leptin (280.41 ± 5.47), and HFD leptin+CoQ10
(298.26±7.08) but not in the HFD+CoQ10 (326.16±7.78) treated group and the control
group, HFD (333.17±3.17) (Table 2). It was also observed that decrease in feed intake
(Fig. IX) started at week 16 when the treatment started among the treatment groups;
HFD + leptin (7.5±0.3) and HFD leptin+CoQ10(9.23± 0.21) but not in the HFD+CoQ10
group (9.5±0.28) and the control group, HFD (9.85±0.36) (Table 3). This result is in
consistent with the study conducted by Pelleymounter et al. (1995)58 and Halaas et al.
(1995) 31 that leptin regulates body weight and food intake animals. Coll, Farooqi, and
O’Rahilly (2007)19 findings also showed that leptin plays a major role in the downstream
anorexigenic pathways in the reduction of food intake in animals. From this study,
CoQ10 does not have an effect on the body weight and food intake when administered
alone. This result was in line with review by Abdali, Samson, and Grover (2015) 1 that
CoQ10 has no effect on the body weight and fat mass. In recent research conducted by
Gopi, Purushotha, and Chandrasek (2015)8 in broiler chicks, it was observed that CoQ10
does not have an effect on the feed intake or body weight when administered alone.
The role of leptin in fertility was also observed in this study. Previous researches
have shown that leptin administration reverses obesity-induced infertility 25.35,82. The
irregularity of the oestrus cycle was first noticed at the end of the 12th week in the HFD
groups. At the 16th week, it was observed that the rats in the HFD groups had disrupted
estrous cycle indicating infertility. Normal regular oestrus cycle in female rats is between
4-5 days. Oestrus cycle consists of proestrus, estrus, metestrus and diestrus phases.
The continuation of a particular phase of the cycle for more than 2 days or skipping of
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estrus phase signified infertility in the rats. Leptin administration restored fertility and
oestrus cycle became regular in the HFD leptin and HFDLeptin+CoQ10 treatment
groups. It was observed that the HFD control group still maintained the irregular oestrus
cycle 2 weeks after treatment. This result supported the study conducted by Chehab
(1997)18 in obese mice and Hoggard, Hunter, Trayhurn, Williams, and Mercer (1998)35
that administration of exogenous leptin reverses obese-induced infertility in animals.
Previous researches have demonstrated that circulating leptin level in the blood
is lower in males and post-menopausal women when compared with females and
premenopausal women respectively 52,54. In addition, when leptin signaling is disrupted
in rats they do not experience puberty. This is an indication that leptin regulates gonadal
function and reproduction, its deficiency or resistance can result to reproduction
abnormalities 52,54. Studies have shown that leptin has an effect on gonadotropinreleasing hormone (GnRH) at the anterior pituitary gland, thus stimulating the secretion
of serum FSH, LH 54 and estrogen 65. CoQ10 can also help in reproduction 69. CoQ10
helps in synthesis of ATP needed by tissues (oocyte) for the process of ovulation,
implantation and embryo development 10. In this study, it was observed that there was
an insignificant increase (p>0.05) in the level of plasma LH in the HFD leptin and HFD
leptin+CoQ10 treatment groups when compared with the control HFD. This result
showed that leptin may induce plasma LH concentration. The insignificant increase
observed might be connected to the follicular stage when the sample was collected
because LH and FSH tend to increase from early follicular stage – mid follicularovulation and the peak observe at the luteal stage of follicular developement before
declining back to the early follicular stage 29. Results from Moschos, Chan, and
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Mantzoros, (2002)54; Yu, Kimura, Walczewska, Karanth, and McCann, (1997)80; Donato
et al. (2009)22 studies indicated that leptin stimulates the production of LH and FSH in
the blood. The result (Fig.11) from plasma FSH concentration showed significance
increase (p<0.05) in plasma FSH in HFDleptin+CoQ10 treated group when compared
with the HFD control group. This indicates that combination of leptin and CoQ10 could
stimulate an increase in the concentration of FSH in the blood. This is a novel finding as
previous studies have suggested that CoQ10 if combined with another compound could
help improve fertility 62,69.
While there are conflicting reports on the role of leptin on plasma estrogen, some
researchers asserted that leptin does not have effects on plasma estrogen while other
believe that leptin plays a role in the regulation of plasma estrogen29. The result from
Shimizu et al. (1997) shows that leptin increases the level of estrogen in female rats 65.
The result of our study showed that leptin has a slight insignificance increase (p>0.05)
in the level of plasma estrogen in the HFD leptin treatment group when compared with
the control group, HFD. There was no significance difference (p>0.05) in the level of
HFDleptin+CoQ10 and CoQ10 treatment groups when compared with the control, HFD.
This suggests that leptin and CoQ10 may not have direct effects on plasma estrogen.
However, this insignificant difference maybe dependent on the estrous stage which the
sample was collected. Estrogen (like leptin) decreases feed intake, reduce body weight
as well as energy expenditure 84. Estrogen tends to induce leptin. The effects of
estrogen can be mimicked by leptin action which can be the result of insignificant
difference observed in estrogen level in HFD leptin and HFDleptin+CoQ10 when
compared with HFD.
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The observational changes noticed in the reproductive hormones from this study
may be connected to the phase of the estrous cycle when the blood sample was
collected. Leptin which is also a regulator of gonadal function and reproduction is
dependent on the functional stage of the estrous cycle. Several studies have shown that
leptin concentration increases from early follicular stage to mid-follicular to ovulatory
and reach the peak level in early luteal phase and start declining in late luteal phase to
early follicular stage, and this can be attributed with adipocyte leptin gene expression
44,52

.
CoQ10 significantly increases (p<0.05) the concentration of plasma leptin (Fig

10). This shows that combination of CoQ10 with leptin could enhance the effect of leptin
in decreasing body weight, food intake, increasing energy expenditure as well as
improving reproduction 69.
It was observed that combination of leptin with CoQ10 significantly increased
(p<0.05) the level of antioxidants present in the blood when compared
HFDleptin+CoQ10 group with the HFD control group (Fig.19). This indicates that the
combined effect of CoQ10 and leptin could help to reduce oxidative stress, the amount of
oxidants and thus quench the free radicals that cause DNA damage especially in the
reproductive organs and conversely promoting fertility. This is suggestive that higher
amount of plasma antioxidant level could produce a positive effect in fertility and
improve reproductive functions especially against oxidative stress and DNA damage in
the reproductive system. This result is consistent with Tarnopolsky (2008)69 submission
that supplementation of antioxidants with another compound produces a more positive
effect than lone administration.
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Another observation from this study is that combination of leptin and CoQ10
significantly increases (p<0.05) the total body calories of the rats when compared with
the control group. This may be due in parts to the higher level of body crude fat
measured by Soxhlet (Fig. 14) as amount of calories tends to increase with an increase
in fat.
From the study, it was observed that CoQ10 significantly increased (p<0.05) the
spleen weight in HFDCoQ10 and HFDleptin+CoQ10 treatments group when compared
with the HFD group (Fig. 18). This shows that CoQ10 increases spleen weight and
therefore is involved in the immunological response of the body. This supports the
previous observation by Gopi, Purushotha, and Chandrasek, (2015)28 in broiler chick
that CoQ10 supplementation at 20 mg kg–1 increases the spleen weight.
As expected, combination of leptin with CoQ10 does not have an effect on the
total crude protein of the rats. There was no significance difference among the groups
(p>0.05) (Fig. 15).
β- catenin and E-cadherin are among the major structural proteins found in the
ovary to maintain epithelial integrity. They assemble to form cell to cell adherence
junction for E-cadherin/ β- catenin complex in the ovary. E-cadherin/ β- catenin complex
has been found to be involved in follicular development, ovulation and corpus luteum
formation in immature rat ovary 67. These proteins are also highly expressed in benign
and malignant tumor epithelial cells 67, acting as a tumor suppressor20.
One of the novel findings of the study is that CoQ10 down-regulates the
expression of β- catenin in the rat ovary. It was observed that CoQ10 significantly down61

regulates (p<0.05) the expression of ߚ- catenin in the treatment groups, HFDCoQ10 and
HFD leptin +CoQ10 when compared with the HFD control group. Leptin effects also
significantly down-regulates (p<0.05) the expression of β- catenin in HFD leptin group
when compared with the HFD control group. The observation from this study suggests
that CoQ10 may have a negative effect on β-catenin in providing cell-to cell adhesion,
ovulation as well as follicular development of the ovary. On the other hand, β-catenin
(as well as E-cadherin) is mostly expressed (biomarkers) in metastatic tissues and
cancer cells67, the down-regulation of this protein maybe an indication for protective role
of CoQ10 in the ovary.
The expression of E-cadherin was not detected at 135kDa, however, there was a
consistent expression of an unknown protein at 50kDa which binds with E-cadherin
antibody. The observation from this study suggests that E-cadherin may have a
particular stage at which it is adequately expressed in the ovary since the follicular
stage of development for the study was not established when the sample was collected.
Research conducted by Davies (1998) compared the expression of E- cadherin in
normal ovarian epithelium, benign and malignant ovarian tumor 67. The result showed
no expression of E- cadherin detection in four out of six normal ovaries examined and
the other two ovaries showed very superficial expression. Although, E- cadherin
expression was detected in normal fallopian tube and mammary gland (but not the
ovary). However, expression of E-cadherin was detected in twenty-eight out of the thirty
differentiated ovarian carcinomas examined 20. In another study conducted by
Sundfeldt, Piontkewitz, Billig, and Hedin (2000)67 using rat ovary, E-cadherin expression
was not detected in antral follicular but in the theca, interstitial cells, surface epithelium
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of immature ovary and higher expression in benign and cancer cells 67. E-cadherin and
β- catenin serve as biomarkers for cancer and metastatic cells. Observation from this
study suggests that E-cadherin may not be detected in normal rat ovary and also
dependent on the follicular stage of development as well as the age of the ovary.
The expression of long isoform (125kDa) and short isoform (100kDa) leptin
receptor (LEPTR) from the hypothalamus lysate was not detected in this study.
However, small proteins (lesser than 70kDa) that bind with the polyclonal leptin receptor
antibody were detected. These proteins may be small short isoforms of leptin receptors
(ob-Ra, ob -Rc, ob-Rd, ob-Re or ob-Rf). The small protein which showed highest
expression was quantified. The result showed statistical significance (p<0.05) decrease
in HFD leptin and HFD leptin+CoQ10 when compared with HFD control group. However,
comparing the two control groups, the normal diet (RCD) showed statistical significance
increase (p<0.05) when compared with high-fat diet group (HFD). This result indicates
that leptin may downregulate the small protein that binds with LEPTR antibody at
50kDa.
Conclusion
Overall, this research supports that combination of leptin with CoQ10 can play a
significant role in biological functions that could results in an increase in reproductive
functions as well as fertility in obese infertile female rats. The regular estrous cycle was
restored after administration with leptin+CoQ10. The administration of combined leptin
and CoQ10 increases the level of reproductive hormones, with significance increase (p <
0.05) in the level of follicle stimulating hormone while luteinizing hormone and estrogen
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showed insignificance increase (P > 0.05) in the blood. These reproductive hormones
help the ovary in folliculization as well as preparedness for ovulation. Leptin and CoQ10
increased the concentration of antioxidant and improved immune function in the rats.
Future Direction
This experiment should be carried out in a larger sample size with male
/pregnant female models, evaluating the reproductive hormones and number of pups.
Emphasis should be made on estrous cycle stages during collection of samples. The
unidentified protein expression detected at 50kDa with E-cadherin antibody and the
small proteins expressed below 70kDa with leptin receptors antibody should be
analyzed for further studies.
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